Both in Biotechnology
Monte Rosa Therapeutics vs Sana Biotechnology
Over the past year GLUE returned −13.8% and SANA returned −46.6%; their daily moves had a correlation of 0.36.
GLUE −13.8% SANA −46.6%Growth of $1, one year, split-adjusted
| Metric | GLUE | SANA |
|---|---|---|
| Price | $10.41 | $2.44 |
| Market cap | $888.1M | $730.4M |
| Today | −2.07% | +1.67% |
| 1 month | +1.4% | −15.3% |
| 6 months | −46.2% | −30.1% |
| Year to date | −33.6% | −40.0% |
| 1 year | −19.0% | −50.7% |
| Revenue growth (YoY) | −61.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −483.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 30.9× | — |
| Net cash | $621.1M | $160.5M |
| Dividend yield | — | — |
| Volatility (60d) | 52.5% | 72.6% |
| Short % of float | 41.9% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).